GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions

Obesity

Interventions

DRUG

GLP-1 analogue - semaglutide

GLP-1 analogue - semaglutide - administered once weekly for a total of 12 weeks

OTHER

Placebo

Placebo - administered once weekly for a total of 12 weeks

Trial Locations (1)

The Yale Stress Center: Yale University, New Haven

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT04779697 - GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight | Biotech Hunter | Biotech Hunter